Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0000950170-24-023406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-02-29 | 2024-02-27+ | TYRA | Bensen Daniel | COO | S - Sale | $20.09 | -8,644 | 444.9K | -2% | -$173.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | S | D | 2,050 | $20.00 | 442,836 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-02-27 | S | D | 745 | $20.00 | 450,735 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-28 | S | D | 5,849 | $20.13 | 444,886 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.50. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |